Table 1 Characteristics of patients (n=75), surgery and chemotherapy

From: Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study

Characteristic

No. of patients

%

Patient characteristics

Gender

  

 Female

17

23

 Male

58

77

Age (years); median (range)

59 (39–76)

 

Performance status

  

 0

45

60

 1

28

37

 2

2

3

Number of pack-years; median (range)

45 (9–160)

 

Smoking habits

  

 Continued

31

41

 Stopped

37

49

 Never smoked

7

10

Serum LDH (× ULN); median (range)

0.77 (0.54–3.56)

 

 >1 × ULN

14

19

Tumour characteristics

  

Initial histology (pathologist from participating centres)

  

 Squamous cell carcinoma

32

43

 Adenocarcinoma

23

31

 Large cell carcinoma

9

12

 Poorly differentiated NSCLC

11

14

Tumour stage

  

 1

6

8

 2

44

59

 3

25

33

Mediastinal lymph node enlargement (>1 cm) by CT scan

  

 Yes

61

81

 No

14

19

Tumour localisation

  

 Upper lobe right

31

42

 Middle lobe right

3

4

 Lower lobe right

9

12

 Upper lobe left

11

15

 Lower lobe left

1

1

 Central right

10

13

 Central left

10

13

Characteristics of the surgery

  

 Type of resection:

  

Lobectomy/bilobectomy

28/10

37/13

Pneumonectomy (right/left)

21/16

28/22

 Complete resectiona

  

Yes

43

57

No

32

43

 Radical resection of the primary tumour:

  

Negative margin

63

84

Positive margin

12

16

Activity of the chemotherapy

  

Response after neoadjuvant chemotherapy

  

 CR

7

9

 PR

48

64

 NC

20

27

Pathological response on primary tumour (% of necrosis and fibrosis, two missing)

  

 Median (range)

60% (0–100%)

 

90%

20

27

 <20%

12

16

Downstaging of mediastinal lymph nodes (four missing)

  

 N0

23

32

 N1

22

31

 N2

26

37

  1. CT=computed tomography; LDH=lactate dehydrogenase; NSCLC=non-small-cell lung cancer; ULN=upper limit of normal.
  2. aComplete resection: negative resection margin (R0) and no involvement of the uppermost mediastinal lymph node in the mediastinal lymphadenectomy preparation.